AR101750A1 - Forma sólida de (1-ciano-ciclopropil)amida del ácido (2s,4r)-4-[4-(1-metil-1h-pirazol-4-il)-2-trifluorometil-bencenosulfonil]-1-(1-trifluorometil-ciclopropanocarbonil)pirrolidin-2-carboxílico - Google Patents

Forma sólida de (1-ciano-ciclopropil)amida del ácido (2s,4r)-4-[4-(1-metil-1h-pirazol-4-il)-2-trifluorometil-bencenosulfonil]-1-(1-trifluorometil-ciclopropanocarbonil)pirrolidin-2-carboxílico

Info

Publication number
AR101750A1
AR101750A1 ARP150102816A ARP150102816A AR101750A1 AR 101750 A1 AR101750 A1 AR 101750A1 AR P150102816 A ARP150102816 A AR P150102816A AR P150102816 A ARP150102816 A AR P150102816A AR 101750 A1 AR101750 A1 AR 101750A1
Authority
AR
Argentina
Prior art keywords
trifluorometil
methyl
acid
solid form
ciclopropanocarbonil
Prior art date
Application number
ARP150102816A
Other languages
English (en)
Spanish (es)
Inventor
Thrse Gustaaf De Paepe Anne
Grassmann Olaf
Cueni Philipp
Bartels Bjoern
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR101750A1 publication Critical patent/AR101750A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP150102816A 2014-09-05 2015-09-03 Forma sólida de (1-ciano-ciclopropil)amida del ácido (2s,4r)-4-[4-(1-metil-1h-pirazol-4-il)-2-trifluorometil-bencenosulfonil]-1-(1-trifluorometil-ciclopropanocarbonil)pirrolidin-2-carboxílico AR101750A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14183700 2014-09-05

Publications (1)

Publication Number Publication Date
AR101750A1 true AR101750A1 (es) 2017-01-11

Family

ID=51483334

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150102816A AR101750A1 (es) 2014-09-05 2015-09-03 Forma sólida de (1-ciano-ciclopropil)amida del ácido (2s,4r)-4-[4-(1-metil-1h-pirazol-4-il)-2-trifluorometil-bencenosulfonil]-1-(1-trifluorometil-ciclopropanocarbonil)pirrolidin-2-carboxílico

Country Status (3)

Country Link
AR (1) AR101750A1 (zh)
TW (1) TW201625593A (zh)
WO (1) WO2016034602A1 (zh)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ595073A (en) * 2009-04-20 2012-11-30 Hoffmann La Roche Proline derivatives as cathepsin inhibitors
DK2776392T3 (en) * 2011-11-11 2016-07-04 Hoffmann La Roche PROCESS FOR THE PREPARATION OF 1-acyl-4-PHENYLSULFONYLPROLINAMID DERIVATIVES AND NEW INTERMEDIATE

Also Published As

Publication number Publication date
TW201625593A (zh) 2016-07-16
WO2016034602A1 (en) 2016-03-10

Similar Documents

Publication Publication Date Title
CU24462B1 (es) Derivados de feniltriazol sustituido con hidroxialquilo
MY191581A (en) Anti-pd-1 antibodies
MX2017004539A (es) Polipropileno heterofasico con equilibrio de resistencia/rigidez al impacto mejorado, fluidez de polvo mejorada, emisiones reducidas y baja contraccion.
MX2019009842A (es) Composicion solida que comprende sofosbuvir amorfo.
CL2016001587A1 (es) Derivado basado en 1,2-naftoquinona y método de preparación del mismo.
SG11201709426XA (en) Resin composition, film produced by using the resincomposition, and multilayer structure
MY193650A (en) Extracellular matrix compositions
MX2020002123A (es) Sales de ribociclib y formas en estado sólido de las mismas.
JP2015173751A5 (zh)
NZ731607A (en) Dihydropyrimidin-2- one compounds and medical use thereof
MX2018002416A (es) Derivados de 1,7-diaril-1,6-heptadien-3,5-diona, procedimiento para la preparación y uso de los mismos.
NZ730092A (en) Use of cysteamine in treating infections caused by yeasts/moulds
EA201692154A1 (ru) Перорально распадающаяся пленка
JP2015016294A5 (zh)
MX2017006712A (es) Inhibidor de produccion de metaloproteinasa de matriz.
CL2018001716A1 (es) Reguladores del cftr y métodos para su uso
EP3588637A4 (en) RESIN FOR ENERGY DEVICE ELECTRODE, ENERGY DEVICE ELECTRODE FORMING COMPOSITION, ENERGY DEVICE ELECTRODE, AND ENERGY DEVICE
MX2016013439A (es) Formas solidas de un compuesto farmaceuticamente activo.
AR101750A1 (es) Forma sólida de (1-ciano-ciclopropil)amida del ácido (2s,4r)-4-[4-(1-metil-1h-pirazol-4-il)-2-trifluorometil-bencenosulfonil]-1-(1-trifluorometil-ciclopropanocarbonil)pirrolidin-2-carboxílico
MX2016010662A (es) Compuestos para mejorar la cognicion y comportamiento social en humanos que tienen trastornos neurologicos.
WO2015112168A3 (en) Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
IT201700003232A1 (it) “migliorata pressa piegatrice”
JP2015226493A5 (zh)
UA113442C2 (xx) Ентеросорбент
Chodosh The Art of Neuroscience

Legal Events

Date Code Title Description
FB Suspension of granting procedure